66 Infos zu Rabea Mecklenbrauck

5 Aktuelle Nachrichten

Rabea Mecklenbrauck, MD | Hannover Medical School, Hannover, Germany | AML-440: Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients.

— ... Rabea Mecklenbrauck, Hannover Medical School, Germany. Time and Location: Monday, December 9, 2024: 2:45 PM-4:15PM Grand Hall C (Manchester ...

Rabea Mecklenbrauck, Michael Heuser. The introduction of new targeted therapies to the treatment algorithm of acute myeloid leukemia (AML) offers new ... › bims-almceb

— Rabea Mecklenbrauck, Michael Heuser · CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute ...

3 Profile in Sozialen Netzwerken

Rabea Mecklenbrauck. Student(in), WWU Münster. Essen und Umgebung, Deutschland2 Kontakte. Zum Vernetzen anmelden ...

View Rabea Mecklenbrauck's profile on LinkedIn, the world's largest professional community. Rabea's education is listed on their profile. See the complete ...

Contact information. .ac.uk. Research groups. Vyas Group: Biology and Treatment of Human Myeloid Cancers. Rabea Mecklenbrauck.

1 Business-Profile

Rabea Mecklenbrauck. University of Münster | WWU · Clinic for Internal Medicine A (Hematology, Hemostasis, Oncology and Pneumology) ... Join ResearchGate to ...

3 Bücher zum Namen

Rabea Mecklenbrauck. Westfälische Wilhelms-Universität Münster, Reviews. Reviews aren't verified, but Google checks for and removes fake content ... › about

6 Dokumente

von PR Hamann · · Zitiert von: 323 — Rabea Mecklenbrauck, Michael Heuser. Resistance to targeted therapies in acute myeloid leukemia. Clinical & Experimental Metastasis 2023,

— Rabea Mecklenbrauck Monday, Dec :00–15:15. Influence of bone marrow blast enumeration and co-occurring myelodysplasia related gene ...

— ... Rabea Mecklenbrauck, Klaus Metzeler, Ken Mills, Renate Schulze Rath, Jordi Sierra Gil, Marta Sobas, Ian Thomas, Laura Tur, Peter Valk ...

— Referent*in: Rabea Mecklenbrauck (Hannover, D). Posterdiskussion. 13: :00. M. Kopf-Hals-Tumoren, Melanome, neuroendokrine Tumoren, Sarkome ...

6 Wissenschaftliche Publikationen

von R Mecklenbrauck · — AML-440 Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients. Author links open overlay panel. Rabea Mecklenbrauck MD 1 , Nora Borchert ...

von M Bader · — , Felicitas Thol 1 , Michael Heuser MD 1 7 , Rabea Mecklenbrauck Show more. Add to Mendeley. Share. Cite. https://doi.org blood

von R Chale · — Rabea Mecklenbrauck MD1, Nora Borchert RA1,. Piroska Klement MD1, Carolin Funke RA1,. Maximilian Brandes RA1, Louisa-Kristin Dallmann RA1,. › article › pii › pdf

ŽiniatinklisDr. Rabea Mecklenbrauck. PhD Students Fiorella Charles Katrin Teich Jyoti Kandarp. Technische Mitarbeiter Kerstin Görlich Nadine Kattre Blerina Neziri …

4 Allgemeine Veröffentlichungen

— Rabea Mecklenbrauck · Rabea Mecklenbrauck. This person is not on ResearchGate, or hasn't claimed this research yet.

von R Mecklenbrauck · · Zitiert von: 3 — Rabea Mecklenbrauck & Michael Heuser. Authors. Rabea Mecklenbrauck. View author publications. You can also search for this author in PubMed ...

— Request PDF | On Oct 1, 2022, Rabea Mecklenbrauck and others published Poster: AML-440 Prognosis of Molecularly-Defined Secondary Acute ...

ŽiniatinklisFormulieren Sie Ihre Suchanfrage genauer. Sie können festlegen, ob einer der Suchbegriffe, eine genaue Wortfolge oder alle Suchbegriffe in den Ergebnissen …

31 Webfunde aus dem Netz

Rabea Mecklenbrauck · X · No public information available.

von R Chale · · Zitiert von: 1 — Rabea Mecklenbrauck MD1, Nora Borchert RA1,. Piroska Klement MD1, Carolin Funke RA1,. Maximilian Brandes RA1, Louisa-Kristin Dallmann RA1,. Walter Fiedler Prof ...

Rabea Mecklenbrauck, Nora Borchert, Piroska Klement, et al Prognostic Impact of Clonality of Myelodysplasia-Related Gene Mutations in AML ...

Rabea Mecklenbrauck (aktuell beurlaubt wegen Forschungsaufenthalt UK); Dr. Franco Morbiducci (Palliativmedizin, FA Neurologie, Funktionsoberarzt); Dr ...

... Rabea Mecklenbrauck. DOI: https://doi.org blood IF: Blood. Abstract:Introduction: Measurable residual disease (MRD) plays ...

Rabea Mecklenbrauck,; Nora Borchert,; Piroska Klement, ... Arnold Ganser,; Felicitas Thol,; Michael Heuser. Published in issue: October S251-S252. PDF ...

Rabea Mecklenbrauck, MD1,2*, Angela Villaverde Ramiro3*, Eric Sträng, PhD4*, Razif Gabdoulline1*, Javier MartÃnez Elicegui3*, Marta Sobas, MD5*, Lisa ...

von R Mecklenbrauck · · Zitiert von: 10 — Authors. Rabea Mecklenbrauck , Michael Heuser. Affiliations. 1 Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation ...

Rabea Mecklenbrauck, Michael Heuser. 202⒊ Resistance to targeted therapies in acute myeloid leukemia. Clinical & Experimental Metastasis 40:1, 33-4⒋ ...

Metastasis (IF 4.2)Rabea Mecklenbrauck, Michael Heuser. Pub Date: NF-κB: A Druggable Target in Acute Myeloid Leukemia. Cancers (IF 4.5)Barbara Di ...

— Rabea Mecklenbrauck. Blood | VOL Maximilian Bader, et. al.Maximilian Bader ... Rabea Mecklenbrauck. 28 Nov Save. Abstract PR

— Prognostic Impact of Clonality of Myelodysplasia-Related Gene Mutations in AML. Rabea Mecklenbrauck,. Rabea Mecklenbrauck. 1Department of ...

— Rabea Mecklenbrauck,. Rabea Mecklenbrauck. 20Shared senior authorship, Department of Hematology, Hemostasis, Oncology and Stem Cell ...

— “Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients.” First author: Rabea Mecklenbrauck, MD, of the Hannover Medical ...

ŽiniatinklisRabea Mecklenbrauck, Bönen. Ansprechpartner und Kontaktdaten der Pressestelle der Staatskanzlei für Journalistinnen und Journalisten

von R Mecklenbrauck · — AML-440 Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients ; Rabea Mecklenbrauck, MD. Rabea Mecklenbrauck ; Nora Borchert, RA. Nora ... › ...

Resistance to targeted therapies in acute myeloid leukemia: (2022) Rabea Mecklenbrauck, Michael Heuser. Check this box to post anonymously. › journals

ŽiniatinklisRabea Mecklenbrauck Alexandra Brock Tharusan Thevathasan Carla Norwig Andreas Cüppers Stefan Kahnert Martin Rehbeck: Projektbeschreibung ...

Clin. Exp. Metastasis (IF 4.51) Pub Date : Posted On : Rabea Mecklenbrauck, Michael Heuser. Portal vein tumor thrombosis in ... › paper

Rabea Mecklenbrauck, Michael Heuser. The introduction of new targeted therapies to the treatment algorithm of acute myeloid leukemia (AML) offers new ... › journal